.
BIOC financial statements
* Numbers in thousands
| Capitalization * | 23 809 |
|---|---|
| EV * | 65 933 |
| Number of shares * | 11 845 |
| EPS | -1,50 |
| Revenue * | 27 461 |
| Net income * | -17 807 |
| Operating profit * | -15 468 |
| Total liabilities * | 23 759 |
| Net debt * | -3 599 |
| Total assets * | 47 452 |
| Equity * | 23 692 |
| Cash and investments * | 14 368 |
.
BIOC valuation
| P/E | -1,34 |
|---|---|
| P/B | 1,00 |
| P/S | 0,87 |
| E/P | -75 |
| P/FCF | -1,15 |
.
BIOC profitability
| ROE | -75% |
|---|---|
| ROA% | -38% |
| ROIC% | -44% |